These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7891309)

  • 1. Degradation of antiflammin 2 in aqueous solution.
    Wolfe JL; Lee GE; Potti GK; Gallelli JF
    J Pharm Sci; 1994 Dec; 83(12):1762-4. PubMed ID: 7891309
    [No Abstract]   [Full Text] [Related]  

  • 2. Oxidative degradation of antiflammin 2.
    Ye JM; Wolfe JL
    Pharm Res; 1996 Feb; 13(2):250-5. PubMed ID: 8932445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Degradation of antiflammin 2 under acidic conditions.
    Ye JM; Lee GE; Potti GK; Galelli JF; Wolfe JL
    J Pharm Sci; 1996 Jul; 85(7):695-9. PubMed ID: 8818992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of phospholipase A2 by uteroglobin and antiflammin peptides.
    Miele L; Cordella-Miele E; Facchiano A; Mukherjee AB
    Adv Exp Med Biol; 1990; 279():137-60. PubMed ID: 2151414
    [No Abstract]   [Full Text] [Related]  

  • 5. A stability-indicating HPLC assay with diode array detection for the determination of a benzylpenicillin prodrug in aqueous solutions.
    Jain R; Wu Z; Tucker IG
    J Pharm Biomed Anal; 2009 Dec; 50(5):841-6. PubMed ID: 19640667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of a high performance liquid chromatography method for the stabilization of epigallocatechin gallate.
    Fangueiro JF; Parra A; Silva AM; Egea MA; Souto EB; Garcia ML; Calpena AC
    Int J Pharm; 2014 Nov; 475(1-2):181-90. PubMed ID: 25175728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solid state chemical instability of an asparaginyl residue in a model hexapeptide.
    Oliyai C; Patel JP; Carr L; Borchardt RT
    J Pharm Sci Technol; 1994; 48(3):167-23. PubMed ID: 8069519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of an anti-stroke peptide: driving forces and kinetics in chemical degradation.
    Li R; Wang F; Chen L; Zhu S; Wu L; Jiang S; Xu Q; Zhu D
    Int J Pharm; 2014 Sep; 472(1-2):148-55. PubMed ID: 24929015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of degradation kinetics for abamectin in formulations using a stability indicating method.
    Awasthi A; Razzak M; Al-Kassas R; Harvey J; Garg S
    Acta Pharm; 2013 Mar; 63(1):59-69. PubMed ID: 23482313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of endogenous hemorphin-related hemoglobin fragments from bovine brain.
    Karelin AA; Philippova MM; Karelina EV; Ivanov VT
    Biochem Biophys Res Commun; 1994 Jul; 202(1):410-5. PubMed ID: 8037741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability and degradation profiles of Spantide II in aqueous solutions.
    Kikwai L; Babu RJ; Kanikkannan N; Singh M
    Eur J Pharm Sci; 2006 Feb; 27(2-3):158-66. PubMed ID: 16266798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of viscosity on the deamidation rate of a model Asn-hexapeptide.
    Li R; Hageman MJ; Topp EM
    J Pept Res; 2002 May; 59(5):211-20. PubMed ID: 11966978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiflammin-2, a nonapeptide of lipocortin-1, inhibits leukocyte chemotaxis but not arachidonic acid mobilization.
    Moreno JJ
    Eur J Pharmacol; 1996 Oct; 314(1-2):129-35. PubMed ID: 8957228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoxazoles. 9. Degradation kinetics of 4-(isoxazolylamino)-1,2-naphthoquinone in acidic aqueous solution.
    Ortiz CS; de Bertorello MM
    J Pharm Sci; 1994 Oct; 83(10):1457-60. PubMed ID: 7884669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The C-terminus and linker region of S100B exert dual control on protein-protein interactions with TRTK-12.
    McClintock KA; Van Eldik LJ; Shaw GS
    Biochemistry; 2002 Apr; 41(17):5421-8. PubMed ID: 11969402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Degradation kinetics of butylmethoxydibenzoylmethane (avobenzone) in aqueous solution.
    Mbah CJ
    Pharmazie; 2007 Oct; 62(10):747-9. PubMed ID: 18236778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of new potential ACE inhibitor in the aqueous solutions of different pH.
    Roskar R; Simoncic Z; Gartner A; Kmetec V
    J Pharm Biomed Anal; 2009 Feb; 49(2):295-303. PubMed ID: 19135817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of pramlintide degradation in aqueous solution as a function of temperature and pH.
    Kenley RA; Tracht S; Stepanenko A; Townsend M; L'Italien J
    AAPS PharmSciTech; 2000 Mar; 1(2):E7. PubMed ID: 14727840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Degradation kinetics of antagonist [Arg6, D-Trp7,9, MePhe8]-substance P [6-11] in aqueous solutions.
    Reubsaet JL; Beijnen JH; Bult A; van der Houwen OA; Teeuwsen J; Koster EH; Underberg WJ
    Anal Biochem; 1995 May; 227(2):334-41. PubMed ID: 7573955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanosizing drug particles in supercritical fluid processing.
    Pathak P; Meziani MJ; Desai T; Sun YP
    J Am Chem Soc; 2004 Sep; 126(35):10842-3. PubMed ID: 15339159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.